Registration of medicines in the USA – review of opportunities and advice from a former FDA employee
• Basic regulatory documents and business recommendations issued by the FDA and ICH;
• Requirements to innovative drugs;
• Peculiarities of registration of new biotechnological products;
• Peculiarities of registration of generics and bio-analogs;
• Accelerated registration programs offered by the FDA for severe diseases.
Skolkovo Intellectual Property Center, LLC